eScholarship Repository eScholarship Repository California Digital Library
eScholarship > UCIEM > WESTJEM > Volume 9 > Issue 4 > Article 3

Journal home

Editorial board

Print subscriptions

Submission guidelines

Images in EM guidelines

Submit article

Conflicts of interest

Concise Academic Writing

Reviewer instructions

Peer review policy

Peer reviewer training module

Journal history

Journal roles

All issues

Search this journal

Notify me of new papers

Contact us

journal_logo
Western Journal of Emergency Medicine
University of California, Irvine
ISSN: 1936-9018


Volume 9, Issue 4 2008

The Effect of Single-Bolus Etomidate on Septic Patient Mortality: A Retrospective Review
Karis L. Tekwani, MD, Advocate Christ Medical Center, Department of Emergency Medicine
Hannah F. Watts, MD, Advocate Christ Medical Center, Department of Emergency Medicine
Cindy W. Chan, MD, Advocate Christ Medical Center, Department of Emergency Medicine
Steve Nanini, MD, Advocate Christ Medical Center, Department of Emergency Medicine
Kathleen H. Rzechula, RN, Advocate Christ Medical Center, Department of Emergency Medicine
Erik B. Kulstad, MS, MD, Advocate Christ Medical Center, Department of Emergency Medicine

Download the Paper (PDF format) - November 14, 2008 Tell a colleague about it.
Printing Tips: Select 'print as image' in the Acrobat print dialog if you have trouble printing. This work has been peer reviewed.

ABSTRACT:

Background: Because of its many desirable properties, etomidate is widely used as an induction agent for endotracheal intubation. However, some have recently called into question the safety of etomidate for even single-bolus use due to its known effects on adrenal suppression.

Objectives: We sought to compare the in-hospital mortality between septic patients given etomidate and those given alternative induction agents for intubation.

Methods: We performed a retrospective chart review of intubated septic patients treated in our hospital. We collected data from patients over the age of 18 with sepsis who were intubated in the pre-hospital setting, in our emergency department, or on the wards of our hospital, and calculated the in-hospital mortality of each group.

Results: We identified 181 patients with sepsis who were intubated over the study period; 135 received etomidate and 46 received alternative agents or no induction agent. Baseline characteristics, vital signs, and laboratory values were similar between the two groups. Of the 46 patients receiving alternative agents or no agent, 18 died, yielding an unadjusted mortality of 39.1% (95% CI 25.5% to 54.6%), while of the 135 patients receiving etomidate, 63 died, for an unadjusted mortality of 46.7% (95% CI 38.1% to 55.4%), P=0.38.

Conclusion: We found a non-statistically significant 7.6% absolute increase in mortality in patients given etomidate in our small-sized study population.

[WestJEM. 2008;9:195-200.]

KEYWORDS:
Septic shock, intubation, infection, etomidate, mortality

SUGGESTED CITATION:
Karis L. Tekwani, MD; Hannah F. Watts, MD; Cindy W. Chan, MD; Steve Nanini, MD; Kathleen H. Rzechula, RN; and Erik B. Kulstad, MS, MD (2008) "The Effect of Single-Bolus Etomidate on Septic Patient Mortality: A Retrospective Review", Western Journal of Emergency Medicine: Vol. 9: No. 4, Article 3.
http://repositories.cdlib.org/uciem/westjem/vol9/iss4/art3




 
bar
Open Archives Initiative eScholarship is a service of the California Digital Library bepress